184 related articles for article (PubMed ID: 9463474)
1. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase.
Yan SZ; Huang ZH; Andrews RK; Tang WJ
Mol Pharmacol; 1998 Feb; 53(2):182-7. PubMed ID: 9463474
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase.
Sunahara RK; Dessauer CW; Whisnant RE; Kleuss C; Gilman AG
J Biol Chem; 1997 Aug; 272(35):22265-71. PubMed ID: 9268375
[TBL] [Abstract][Full Text] [Related]
3. Three discrete regions of mammalian adenylyl cyclase form a site for Gsalpha activation.
Yan SZ; Huang ZH; Rao VD; Hurley JH; Tang WJ
J Biol Chem; 1997 Jul; 272(30):18849-54. PubMed ID: 9228061
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.
Tesmer JJ; Sunahara RK; Gilman AG; Sprang SR
Science; 1997 Dec; 278(5345):1907-16. PubMed ID: 9417641
[TBL] [Abstract][Full Text] [Related]
5. Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.
Dessauer CW; Scully TT; Gilman AG
J Biol Chem; 1997 Aug; 272(35):22272-7. PubMed ID: 9268376
[TBL] [Abstract][Full Text] [Related]
6. Two cytoplasmic domains of mammalian adenylyl cyclase form a Gs alpha- and forskolin-activated enzyme in vitro.
Yan SZ; Hahn D; Huang ZH; Tang WJ
J Biol Chem; 1996 May; 271(18):10941-5. PubMed ID: 8631912
[TBL] [Abstract][Full Text] [Related]
7. A guanylyl cyclase from Paramecium with 22 transmembrane spans. Expression of the catalytic domains and formation of chimeras with the catalytic domains of mammalian adenylyl cyclases.
Linder JU; Hoffmann T; Kurz U; Schultz JE
J Biol Chem; 2000 Apr; 275(15):11235-40. PubMed ID: 10753932
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the interface regions involved in interactions between the central cytoplasmic loop and the C-terminal tail of adenylyl cyclase.
Yoo B; Iyengar R; Chen Y
J Biol Chem; 2004 Apr; 279(14):13925-33. PubMed ID: 14722077
[TBL] [Abstract][Full Text] [Related]
9. Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha.
Sutkowski EM; Tang WJ; Broome CW; Robbins JD; Seamon KB
Biochemistry; 1994 Nov; 33(43):12852-9. PubMed ID: 7947691
[TBL] [Abstract][Full Text] [Related]
10. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits.
Qiu R; Tsao J; Kwan WK; Schimmer BP
Mol Endocrinol; 1996 Dec; 10(12):1708-18. PubMed ID: 8961279
[TBL] [Abstract][Full Text] [Related]
11. The conserved asparagine and arginine are essential for catalysis of mammalian adenylyl cyclase.
Yan SZ; Huang ZH; Shaw RS; Tang WJ
J Biol Chem; 1997 May; 272(19):12342-9. PubMed ID: 9139678
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the two cytosolic domains of mammalian adenylyl cyclase.
Whisnant RE; Gilman AG; Dessauer CW
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6621-5. PubMed ID: 8692867
[TBL] [Abstract][Full Text] [Related]
13. Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.
Pinto C; Hübner M; Gille A; Richter M; Mou TC; Sprang SR; Seifert R
Biochem Pharmacol; 2009 Jul; 78(1):62-9. PubMed ID: 19447224
[TBL] [Abstract][Full Text] [Related]
14. The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.
Mitterauer T; Hohenegger M; Tang WJ; Nanoff C; Freissmuth M
Biochemistry; 1998 Nov; 37(46):16183-91. PubMed ID: 9819210
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Gialpha binding site on type V adenylyl cyclase.
Dessauer CW; Tesmer JJ; Sprang SR; Gilman AG
J Biol Chem; 1998 Oct; 273(40):25831-9. PubMed ID: 9748257
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of constitutively active mutants of mammalian adenylyl cyclase.
Hatley ME; Benton BK; Xu J; Manfredi JP; Gilman AG; Sunahara RK
J Biol Chem; 2000 Dec; 275(49):38626-32. PubMed ID: 10982815
[TBL] [Abstract][Full Text] [Related]
17. Identification of an intramolecular interaction between small regions in type V adenylyl cyclase that influences stimulation of enzyme activity by Gsalpha.
Scholich K; Wittpoth C; Barbier AJ; Mullenix JB; Patel TB
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9602-7. PubMed ID: 9275169
[TBL] [Abstract][Full Text] [Related]
18. Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin.
Tang WJ; Gilman AG
Science; 1995 Jun; 268(5218):1769-72. PubMed ID: 7792604
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
Mou TC; Gille A; Fancy DA; Seifert R; Sprang SR
J Biol Chem; 2005 Feb; 280(8):7253-61. PubMed ID: 15591060
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase.
Dessauer CW; Chen-Goodspeed M; Chen J
J Biol Chem; 2002 Aug; 277(32):28823-9. PubMed ID: 12058044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
